Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Fidrisertib 💬1件: Fidrisertib (piperazine-1-carboxylate)1件: Fidrisertib1件: ACVR1 💬 5件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hormone signaling, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 272 💬
2 Piperazine 💬
(Piperazine (USP))		1件: Piperazine (Piperazine sulfate)1件: Piperazine--1件: 272 💬
3 Piperazine adipate 💬
(Piperazine adipate (JP18/USP))		1件: Piperazine (Piperazine sulfate)1件: Piperazine--1件: 272 💬
4 Piperazine citrate 💬
(Piperazine citrate (USP), Piperazine citrate hydrate)		1件: Piperazine (Piperazine sulfate)1件: Piperazine--1件: 272 💬
5 Piperazine hexahydrate 💬
(Piperazine hexahydrate)		1件: Piperazine (Piperazine sulfate)1件: Piperazine--1件: 272 💬
6 Piperazine phosphate 💬
(Piperazine phosphate (USP), Piperazine phosphate hydrate (JP18))		1件: Piperazine (Piperazine sulfate)1件: Piperazine--1件: 272 💬
7 Terazosin 💬1件: Terazosin (1-piperazine)1件: Terazosin3件: ADRA1A,
ADRA1B,
ADRA1D 💬 		9件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 6 💬
8 Terazosin hydrochloride 💬1件: Terazosin (1-piperazine)1件: Terazosin3件: ADRA1A,
ADRA1B,
ADRA1D 💬 		9件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 6 💬